Follow
Sucheta D'Sa
Title
Cited by
Cited by
Year
Cancer chemotherapy: Effect of poloxamer modified nanoparticles on cellular function
GL Allotey-Babington, H Nettey, S D’Sa, KB Gomes, MJ D'Souza
Journal of Drug Delivery Science and Technology 47, 181-192, 2018
172018
Transdermal vaccination with the matrix-2 protein virus-like particle (M2e VLP) induces immunity in mice against influenza A virus
K Braz Gomes, S D’Sa, GL Allotey-Babington, SM Kang, MJ D’Souza
Vaccines 9 (11), 1324, 2021
132021
Biofabrication of microcapsules encapsulating beta-TC-6 cells via scalable device and in-vivo evaluation in type 1 diabetic mice
A Bansal, S D'Sa, MJ D'Souza
International Journal of Pharmaceutics 572, 118830, 2019
102019
Trends in Nonparenteral Delivery of Biologics, Vaccines and Cancer Therapies
MJ D’Souza, RP Gala, RV Ubale, B D’Souza, TP Vo, AC Parenky, ...
Novel approaches and strategies for biologics, vaccines and cancer therapies …, 2015
102015
Dendritic cell activation by a micro particulate based system containing the influenza matrix-2 protein virus-like particle (M2e VLP)
KB Gomes, GL Allotey-Babington, S D'Sa, SM Kang, MJ D'Souza
International journal of pharmaceutics 622, 121667, 2022
42022
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity
S D’Sa, K Braz Gomes, GL Allotey-Babington, C Boyoglu, SM Kang, ...
Vaccines 10 (4), 584, 2022
32022
Emerging trends in delivery of novel vaccine formulations
TP Vo, RP Gala, T Chandran, S D’Sa, RV Ubaleb
Nanoparticulate Vaccine Delivery Systems, 15, 2015
12015
Promising Immunotherapeutic Strategies for Cancer and Infectious Disease and Evaluation of Cell-Loaded Hydrogels for Type 1 Diabetes
S D'SA
2021
Oral Microparticulate Vaccine for Melanoma
B D’Souza, G Bumgarner, S D’Sa
Nanoparticulate Vaccine Delivery Systems, 157, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–9